December, 2022 (7)

• A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
  Nyang'wa B-T, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Solodovnikova V, Liverko I, Moodliar R, Dodd M, Ngubane N, Rassool M, McHugh TD, Spigelman M, Moore DAJ, Ritmeijer K, du Cros P, Fielding K; TB-PRACTECAL Study Collaborators.
  N Engl J Med. 2022 Dec; 387(25):2331-2343
• Analysis of four syringe dispensing machine point-of-access data 2017-2020 in Melbourne, Australia: machine utilisation and client demographics.
  Kerr P, Cossar RD, Livingston M, Jacka D, Dietze P, O'Keefe D
  Harm Reduct J. 2022 Dec; 19(1):144
• Population heterogeneity in Plasmodium vivax relapse risk.
  Stadler E, Cromer D, Mehra S, Adekunle AI, Flegg JA, Anstey NM, Watson JA, Chu CS, Mueller I, Robinson LJ, Schlub TE, Davenport MP, Khoury DS
  PLoS Negl Trop Dis. 2022 Dec; 16(12):e0010990
• "Like a pickle that's been unpickled": Emotional, identity and behavioural transformations throughout hepatitis C treatment.
  Goutzamanis S, Doyle JS, Horyniak D, Higgs P, Hellard M
  PLoS One. 2022 Dec; 17(12):e0272401
• Associated factors and global adherence of cervical cancer screening in 2019: a systematic analysis and modelling study.
  Zhang W, Gao K, Fowkes FJI, Adeloye D, Rudan I, Song P, Jin M, Chen K
  Global Health. 2022 Dec; 18(1):101
• Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial.
  McMahon JH, Lau JSY, Coldham A, Roney J, Hagenauer M, Price S, Bryant M, Garlick J, Paterson A, Lee SJ, O'Bryan J, Hearps A, Tachedjian G, Pinskier H, Phillips C, Garrow S, Pinskier N, Melvin R, Blakeway L, Wisniewski JA, Byers S, Badoordeen GZ, Pereira S, Pragastis K, Trubiano JA, Chua KYL, Kainer M, Molton JS, Gardiner BJ, Pierce AB, Cheng A, Rogers BA, Peleg AY
  EClinicalMedicine. 2022 Dec; 54:101703
• Drivers of COVID-19 vaccine hesitancy among women of childbearing age in Victoria, Australia: A descriptive qualitative study.
  Oliver J, Kaufman J, Bagot K, Bradfield Z, Homer C, Gibney KB, Danchin M
  Vaccine X. 2022 Dec; 12:100240

November, 2022 (12)

• Targeting malaria parasites with novel derivatives of azithromycin.
  Burns AL, Sleebs BE, Gancheva M, McLean KT, Siddiqui G, Venter H, Beeson JG, O'Handley R, Creek DJ, Ma S, Frölich S, Goodman CD, McFadden GI, Wilson DW
  Front Cell Infect Microbiol. 2022 Nov; 12:1063407
• PfATP4 inhibitors in the Medicines for Malaria Venture Malaria Box and Pathogen Box block the schizont-to-ring transition by inhibiting egress rather than invasion.
  Barnes CBG, Dans MG, Jonsdottir TK, Crabb BS, Gilson PR
  Front Cell Infect Microbiol. 2022 Nov; 12:1060202
• Undetected serovars: leptospirosis cases in the Cairns region during the 2021 wet season.
  Taunton C, Hayek CE, Field E, Rubenach S, Esmonde J, Smith S, Preston-Thomas A
  Commun Dis Intell (2018). 2022 Nov; 46:70
• Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions.
  Wallace J, Richmond J, Howell J, Hajarizadeh B, Power J, Treloar C, Revill PA, Cowie B, Wang S, Stoové M, Pedrana A, Hellard M
  Viruses. 2022 Nov; 14(11):2542
• The RTS,S malaria vaccine: Current impact and foundation for the future.
  Beeson JG, Kurtovic L, Valim C, Asante KP, Boyle MJ, Mathanga D, Dobano C, Moncunill G
  Sci Transl Med. 2022 Nov; 14(671):eabo6646
• Insecticide resistance in malaria and arbovirus vectors in Papua New Guinea, 2017-2022.
  Katusele M, Lagur S, Endersby-Harshman N, Demok S, Goi J, Vincent N, Sakur M, Dau A, Kilepak L, Gideon S, Pombreaw C, Makita L, Hoffmann A, Robinson LJ, Laman M, Karl S
  Parasit Vectors. 2022 Nov; 15(1):426
• Application of Proteomics to the Study of the Therapeutics and Pathogenicity of Giardia duodenalis.
  Ahmad Fudail Eiyad Aziz, Norhamizah Roshidi, Nurulhasanah Othman, Khayriyyah Mohd Hanafiah, Norsyahida Arifin
  Diagnostics (Basel). 2022 Nov; 12(11)
• A Retrospective Cohort Study of Women and Men Living with HIV, Attending an HIV Clinic in Australia.
  Hamilton RA, Wells Y, Higgs P
  Womens Health Rep (New Rochelle). 2022 Nov; 3(1):915-923
• Chlamydia prevention and management in Australia: reducing the burden of disease.
  Munari SC, Goller JL, Hellard ME, Hocking JS
  Med J Aust. 2022 Nov; 217(10):499-501
• A multinational Delphi consensus to end the COVID-19 public health threat.
  Lazarus JV, Romero D, Kopka CJ, Karim SA, Abu-Raddad LJ, Almeida G, Baptista-Leite R, Barocas JA, Barreto ML, Bar-Yam Y, Bassat Q, Batista C, Bazilian M, Chiou ST, Del Rio C, Dore GJ, Gao GF, Gostin LO, Hellard M, Jimenez JL, Kang G, Lee N, Matičič M, McKee M, Nsanzimana S, Oliu-Barton M, Pradelski B, Pyzik O, Rabin K, Raina S, Rashid SF, Rathe M, Saenz R, Singh S, Trock-Hempler M, Villapol S, Yap P, Binagwaho A, Kamarulzaman A, El-Mohandes A; COVID-19 Consensus Statement Panel.
  Nature. 2022 Nov; 611:332-345
• Barriers to women's disclosure of and treatment for substance use during pregnancy: A qualitative study.
  Oni HT, Drake JA, Dietze P, Higgs P, Islam MM
  Women Birth. 2022 Nov; 35(6):576-581
• Left behind on the path to 90-90-90: understanding and responding to HIV among displaced people.
  Vasylyeva TI, Horyniak D, Bojorquez I, Pham MD
  J Int AIDS Soc. 2022 Nov; 25(11):e26031

October, 2022 (19)

• Slow progress towards pneumonia control for children in low-and-middle income countries as measured by pneumonia indicators: A systematic review of the literature.
  Quach A, Spence H, Nguyen C, Graham SM, von Mollendorf C, Mulholland K, Russell FM
  J Glob Health. 2022 Oct; 12:10006
• Vaccination in pregnancy: The role of the midwife.
  Homer CSE, Javid N, Wilton K, Bradfield Z
  Front Glob Womens Health. 2022 Oct; 3:929173
• Twenty-one years at the Uniting Medically Supervised Injecting Centre, Sydney: addressing the remaining questions.
  Day CA, Salmon A, Jauncey M, Bartlett M, Roxburgh A
  Med J Aust. 2022 Oct; 217(8):385-387
• In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications.
  Refaat A, Yap ML, Pietersz G, Walsh APG, Zeller J, Del Rosal B, Wang X, Peter K
  J Nanobiotechnology. 2022 Oct; 20(1):450
• Long-Term Impact of COVID-19 on Hospital Visits of Rural Residents in Guangdong, China: A Controlled Interrupted Time Series Study.
  Zhong W, Yin R, Pan Y, Zhang X, Renzaho AMN, Ling L, Li X, Chen W
  Int J Environ Res Public Health. 2022 Oct; 19(20):13259
• Asia-Pacific ICEMR: Understanding Malaria Transmission to Accelerate Malaria Elimination in the Asia Pacific Region.
  Mueller I, Vantaux A, Karl S, Laman M, Witkowski B, Pepey A, Vinit R, White M, Barry A, Beeson JG, Robinson LJ
  Am J Trop Med Hyg. 2022 Oct; 107(4_Suppl):131-137
• Impact of Environmental Modifications on the Ecology, Epidemiology, and Pathogenesis of Plasmodium falciparum and Plasmodium vivax Malaria in East Africa.
  Yan G, Lee MC, Zhou G, Jiang AL, Degefa T, Zhong D, Wang X, Hemming-Schroeder E, Mukabana WR, Dent AE, King CL, Hsu K, Beeson J, Githure JI, Atieli H, Githeko AK, Yewhalaw D, Kazura JW
  Am J Trop Med Hyg. 2022 Oct; 107(4_Suppl):5-13
• Asia-Pacific International Center of Excellence in Malaria Research: Maximizing Impact on Malaria Control Policy and Public Health in Cambodia and Papua New Guinea.
  Robinson LJ, Laman M, Makita L, Lek D, Dori A, Farquhar R, Vantaux A, Witkowski B, Karl S, Mueller I
  Am J Trop Med Hyg. 2022 Oct; 107(4_Suppl):124-130
• A framework for considering the utility of models when facing tough decisions in public health: a guideline for policy-makers.
  Thompson J, McClure R, Scott N, Hellard M, Abeysuriya R, Vidanaarachchi R, Thwaites J, Lazarus JV, Lavis J, Michie S, Bullen C, Prokopenko M, Chang SL, Cliff OM, Zachreson C, Blakely A, Wilson T, Ouakrim DA, Sundararajan V
  Health Res Policy Syst. 2022 Oct; 20(1):107
• Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques.
  Chua BY, Sekiya T, Koutsakos M, Nomura N, Rowntree LC, Nguyen THO, McQuilten HA, Ohno M, Ohara Y, Nishimura T, Endo M, Itoh Y, Habel JR, Selva KJ, Wheatley AK, Wines BD, Hogarth PM, Kent SJ, Chung AW, Jackson DC, Brown LE, Shingai M, Kedzierska K, Kida H
  PLoS Pathog. 2022 Oct; 18(10):e1010891
• Assessment of the lifetime prevalence and incidence of induced abortion and correlates among female sex workers in Mombasa, Kenya: a secondary cohort analysis.
  Simmelink AM, Gichuki CM, Ampt FH, Manguro G, Lim MSC, Agius P, Hellard M, Jaoko W, Stoové MA, L'Engle K, Temmerman M, Gichangi P, Luchters S
  BMJ Open. 2022 Oct; 12(10):e053218
• The onset and severity of acute opioid toxicity in heroin overdose cases: a retrospective cohort study at a supervised injecting facility in Melbourne, Australia.
  Stam NC, Cogger S, Schumann JL, Weeks A, Roxburgh A, Dietze PM, Clark N
  Clin Toxicol. 2022 Oct; 60(11):1227-1234
• Modelling herd immunity requirements in Queensland: impact of vaccination effectiveness, hesitancy and variants of SARS-CoV-2.
  Sanz-Leon P, Hamilton LHW, Raison SJ, Pan AJX, Stevenson NJ, Stuart RM, Abeysuriya RG, Kerr CC, Lambert SB, Roberts JA
  Philos Trans A Math Phys Eng Sci. 2022 Oct; 380(2233):20210311
• The National COVID-19 Clinical Evidence Taskforce: pregnancy and perinatal guidelines.
  Homer CS, Roach V, Cusack L, Giles ML, Whitehead C, Burton W, Downton T, Gleeson G, Gordon A, Hose K, Hunt J, Kitschke J, McDonnell N, Middleton P, Oats JJ, Shand AW, Wilton K, Vogel J, Elliott J, McGloughlin S, McDonald SJ, White H, Cheyne S, Turner T; National COVID-19 Clinical Evidence Taskforce.
  Med J Aust. 2022 Oct; 217(Suppl 9):S14-S19
• HBV continuum of care using community- and hospital-based screening interventions in Senegal: Results from the PROLIFICA programme.
  Sow A, Lemoine M, Toure PS, Diop M, Lo G, De Veiga J, Pape OT, Seck K, Ndow G, Bojang L, Kane A, Oudiane M, Howell J, Nayagam S, Moutchia J, Chemin I, Mendy M, Toure-Kane C, Thursz M, Ka M, Shimakawa Y, Mboup S
  JHEP Rep. 2022 Oct; 4(10):100533
• The Value of Chest Radiography in Tuberculosis Preventive Treatment Screening in Children and Adolescents.
  Marais BJ, Graham SM
  Am J Respir Crit Care Med. 2022 Oct; 206(7):814-816
• Cost optimisation analysis of the expanded programme for immunisation: balancing equity and coverage in Pakistan.
  Houdroge F, Yunus H, Delport D, Stearns E, Palmer A, Naim A, Kashif A, Pyne HH, Scott N, Oelrichs R, Wilson D
  BMJ Glob Health. 2022 Oct; 7(10)
• Validation of novel point-of-care test for alanine aminotransferase measurement: A pilot cohort study.
  Howell J, Traeger MW, Williams B, Layton C, Doyle JS, Latham N, Draper B, Bramwell F, Membrey D, McPherson M, Roney J, Stoové M, Thompson AJ, Hellard ME, Pedrana A
  Clin Liver Dis (Hoboken). 2022 Oct; 20(4):136-139
• Editorial: Molecular Approaches to Malaria 2020.
  de Koning-Ward TF, Boddey JA, Fowkes FJI
  Int J Parasitol. 2022 Oct; 52(11):705-706

September, 2022 (26)

• Improved rapid diagnostic tests to detect syphilis and yaws: a systematic review and meta-analysis.
  Zhang Y, Goh SM, Mello MB, Baggaley RC, Wi T, Johnson CC, Asiedu KB, Marks M, Pham MD, Fairley CK, Chow EPF, Mitjà O, Toskin I, Ballard RC, Ong JJ
  Sex Transm Infect. 2022 Sep; 98(8):608-616
• Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort study.
  Howell J, Samani A, Mannan B, Hajiev S, Motedayen Aval L, Abdelmalak R, Tam VC, Bettinger D, Thimme R, Taddei TH, Kaplan DE, Seidensticker M, Sharma R
  Therap Adv Gastroenterol. 2022 Sep; 15:17562848221100106
• Band 3-mediated Plasmodium vivax invasion is associated with transcriptional variation in PvTRAg genes.
  De Meulenaere K, Prajapati SK, Villasis E, Cuypers B, Kattenberg JH, Kasian B, Laman M, Robinson LJ, Gamboa D, Laukens K, Rosanas-Urgell A
  Front Cell Infect Microbiol. 2022 Sep; 12:1011692
• Unique evolution of antiviral tetherin in bats.
  Hayward JA, Tachedjian M, Johnson A, Irving AT, Gordon TB, Cui J, Nicolas A, Smith I, Boyd V, Marsh GA, Baker ML, Wang LF, Tachedjian G
  J Virol. 2022 Sep; 96(20):e01152-22
• Access to needles and syringes and methadone maintenance therapy among people who inject drugs in Yangon, Myanmar: a qualitative study.
  Yee WL, Draper B, Myint KT, Min W, Htay H, O'Keefe D, Hellard M
  Harm Reduct J. 2022 Sep; 19(1):107
• Reflections on the in-prison recruitment and participation of men with a history of injecting drug use, in a longitudinal cohort study in Australia.
  Walker S, Curtis M, Woods E, Pierce L, Kirwan A, Stewart AC, Cossar R, Winter R, Dietze P, Kinner SA, Ogloff JRP, Butler T, Stoové M
  J Criminol. 2022 Sep; 55(4):586-603
• Women with hepatitis B: how mothers with chronic hepatitis B understand and experience the prevention of mother-to-child transmission interventions in Victoria, Australia.
  Yussf N, Wallace J, Perrier M, Romero N, Cowie B, Allard N
  Aust J Prim Health. 2022 Sep; 28(6):514-521
• Reducing malaria transmission in forest-going mobile and migrant populations in Lao PDR and Cambodia: protocol for stepped-wedge cluster-randomised controlled trial.
  Htike W, Oo WH, Lynn T, Sovanda L, Agius PA, Oo MC, Galau NH, Thu KM, Zaw AK, Htwe EP, Cutts JC, Kearney EA, Scott N, O'Flaherty K, Wang B, Khamlome B, Vilay P, Siv S, Fowkes FJI
  BMC Infect Dis. 2022 Sep; 22(1):747
• Quarantine preparedness - the missing factor in COVID-19 behaviour change? Qualitative insights from Australia.
  Davis A, Munari S, Doyle J, Sutton B, Cheng A, Hellard M, Gibbs L
  BMC Public Health. 2022 Sep; 22(1):1806
• Improving COVID-19 Vaccine Uptake among Black Populations: A Systematic Review of Strategies.
  Adeagbo M, Olukotun M, Musa S, Alaazi D, Allen U, Renzaho AMN, Sekyi-Otu A, Salami B
  Int J Environ Res Public Health. 2022 Sep; 19(19):11971
• Knowledge and attitudes towards TB among healthcare workers in Yogyakarta, Indonesia.
  Main S, Dwihardiani B, Hidayat A, Khodijah S, Greig J, Chan G, Parry AE, Nababan B, Billy I, du Cros P, Triasih R
  Public Health Action. 2022 Sep; 12(3):133-140
• Twenty-year trends in pharmaceutical fentanyl and illicit fentanyl deaths, Australia 2001-2021.
  Roxburgh A, Nielsen S
  Int J Drug Policy. 2022 Sep; 109:103854
• VIVID: a web application for variant interpretation and visualisation in multidimensional analyses.
  Tichkule S, Myung Y, Naung MT, Ansell BRE, Guy AJ, Srivastava N, Mehra S, Cacciò SM, Mueller I, Barry AE, van Oosterhout C, Pope B, Ascher DB, Jex AR
  Mol Biol Evol. 2022 Sep; 39(9):msac196
• The Lancet Commission on lessons for the future from the COVID-19 pandemic.
  Sachs JD, Karim SSA, Aknin L, Allen J, Brosbøl K, Colombo F, Barron GC, Espinosa MF, Gaspar V, Gaviria A, Haines A, Hotez PJ, Koundouri P, Bascuñán FL, Lee JK, Pate MA, Ramos G, Reddy KS, Serageldin I, Thwaites J, Vike-Freiberga V, Wang C, Were MK, Xue L, Bahadur C, Bottazzi ME, Bullen C, Laryea-Adjei G, Amor YB, Karadag O, Lafortune G, Torres E, Barredo L, Bartels JGE, Joshi N, Hellard M, Huynh UK, Khandelwal S, Lazarus JV, Michie S
  Lancet. 2022 Sep; 400(10359):1224-1280
• A project to validate the GLU test for preterm birth prediction in First Nations women.
  Brown K, Unger HW , Peel M , Doherty DA , Lee M , Kujawa A , Holder S , Tachedjian G, Masson L , Thorn JC, Newnham JP, Payne MS
  Microbiol Austr. 2022 Sep; 43(3):130-134
• Non-Human Primate Models of HIV Brain Infection and Cognitive Disorders.
  Byrnes SJ, Angelovich TA, Busman-Sahay K, Cochrane CR, Roche M, Estes JD, Churchill MJ
  Viruses. 2022 Sep; 14(9):1997
• Modeling the cost and impact of injectable opioid agonist therapy on overdose and overdose deaths.
  Tse WC, Scott N, Dietze P, Nielsen S
  J Subst Abuse Treat. 2022 Sep; 143:108871
• Strengthening assessment and response to mental health needs for Aboriginal and Torres Strait Islander children and adolescents in primary care settings: study protocol for the Ngalaiya Boorai Gabara Budbut implementation project.
  Reilly R, Azzopardi PS, Brown A, Fisher J, Patton G, Rickwood DJ, Yong CS, Pearson O, Brown N
  BMJ Open. 2022 Sep; 12(9):e063154
• Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia.
  O'Keefe D, Livingston M, Cossar RD, Kerr P, Jacka D, Dietze P
  Harm Reduct J. 2022 Sep; 19(1):101
• The Gendered Experience of Close to Community Providers during COVID-19 Response in Fragile Settings: A Multi-Country Analysis.
  Raven J, Arjyal A, Baral S, Chand O, Hawkins K, Kallon L, Mansour W, Parajuli A, Than KK, Wurie H, Yamout R, Theobald S
  Soc Sci. 2022 Sep; 11(9):415
• Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT).
  Vallely AJB, Saville M, Badman SG, Gabuzzi J, Bolnga J, Mola GDL, Kuk J, Wai M, Munnull G, Garland SM, Brotherton JML, Kelly-Hanku A, Morgan C, Toliman PJ, Kombati Z, Kariwiga G, Babona D, Tan G, Simms KT, Cornall AM, Tabrizi SN, Wand H, Guy R, Canfell K, Kaldor JM
  Lancet Glob Health. 2022 Sep; 10(9):e1336-e1346
• Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models.
  Bershteyn A, Jamieson L, Kim HY, Platais I, Milali MP, Mudimu E, Ten Brink D, Martin-Hughes R, Kelly SL, Phillips AN, Bansi-Matharu L, Cambiano V, Revill P, Meyer-Rath G, Nichols BE
  Lancet Glob Health. 2022 Sep; 10(9):e1298-e1306
• Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort.
  Bartlett SR, Verich A, Carson J, Hosseini-Hooshyar S, Read P, Baker D, Post JJ, Finlayson R, Bloch M, Doyle JS, Shaw D, Hellard M, Martinez M, Marks P, Dore GJ, Matthews GV, Applegate T, Martinello M
  Health Sci Rep. 2022 Sep; 5(5):e719
• The Medicines for Malaria Venture Malaria Box contains inhibitors of protein secretion in Plasmodium falciparum blood stage parasites.
  Looker O, Dans MG, Bullen HE, Sleebs BE, Crabb BS, Gilson PR
  Traffic. 2022 Sep; 23(9):442-461
• Detecting Mycobacterium tuberculosis Infection in Children Migrating to Australia.
  Laemmle-Ruff I, Graham SM, Williams B, Horyniak D, Majumdar SS, Paxton GA, Soares Caplice LV, Hellard ME, Trauer JM
  Emerg Infect Dis. 2022 Sep; 28(9):1833-1841
• Multicountry study protocol of COCOON: COntinuing Care in COVID-19 Outbreak global survey of New, expectant, and bereaved parent experiences.
  Loughnan SA, Gautam R, Silverio SA, Boyle FM, Cassidy J, Ellwood D, Homer C, Horey D, Leisher SH, de Montigny F, Murphy M, O'Donoghue K, Quigley P, Ravaldi C, Sandall J, Storey C, Wilson AN, Flenady V (COCOON Global Collaboration)
  BMJ Open. 2022 Sep; 12(9):e061550

August, 2022 (16)

• Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression.
  Delgado-Diaz DJ, Jesaveluk B, Hayward JA, Tyssen D, Alisoltani A, Potgieter M, Bell L, Ross E, Iranzadeh A, Allali I, Dabee S, Barnabas S, Gamieldien H, Blackburn JM, Mulder N, Smith SB, Edwards VL, Burgener AD, Bekker LG, Ravel J, Passmore JS, Masson L, Hearps AC, Tachedjian G
  Microbiome. 2022 Aug; 10(1):141
• Induction, decay, and determinants of functional antibodies following vaccination with the RTS,S malaria vaccine in young children.
  Feng G, Kurtovic L, Agius PA, Aitken EH, Sacarlal J, Wines BD, Hogarth PM, Rogerson SJ, Fowkes FJI, Dobaño C, Beeson JG
  BMC Med. 2022 Aug; 20(1):289
• Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort study.
  Patwala K, Prince DS, Celermajer Y, Alam W, Paul E, Strasser SI, McCaughan GW, Gow P, Sood S, Murphy E, Roberts S, Freeman E, Stratton E, Davison SA, Levy MT, Clark-Dickson M, Nguyen V, Bell S, Nicoll A, Bloom A, Lee AU, Ryan M, Howell J, Valaydon Z, Mack A, Liu K, Dev A
  Hepatol Int. 2022 Aug; 16(5):1170-1178
• Effects and safety of Chinese herbal medicine on inflammatory biomarkers in cardiovascular diseases: A systematic review and meta-analysis of randomized controlled trials.
  Li M, Zhou IW, Trevillyan J, Hearps AC, Zhang AL, Jaworowski A.
  Front Cardiovasc Med. 2022 Aug; 9:922497
• Functional inactivation of Plasmodium falciparum glycogen synthase kinase GSK3 modulates erythrocyte invasion and blocks gametocyte maturation.
  Alder A, Wilcke L, Pietsch E, von Thien H, Pazicky S, Löw C, Mesen-Ramirez P, Bachmann A, Burda PC, Kunick C, Sondermann H, Wilson D, Gilberger TW
  J Biol Chem. 2022 Aug; 298(9):102360
• Assessment of IgG3 as a serological exposure marker for Plasmodium vivax in areas with moderate-high malaria transmission intensity.
  Tayipto Y, Rosado J, Gamboa D, White MT, Kiniboro B, Healer J, Opi DH, Beeson JG, Takashima E, Tsuboi T, Harbers M, Robinson L, Mueller I, Longley RJ
  Front Cell Infect Microbiol. 2022 Aug; 12:950909
• Exploring Tuberculosis Riskscapes in a Papua New Guinean 'Hotspot'.
  Jops P, Kupul M, Nake Trumb R, Cowan J, Graham SM, Bell S, Majumdar S, Nindil H, Pomat W, Marais B, Marks G, Vallely AJ, Kaldor J, Kelly-Hanku A
  Qual Health Res. 2022 Aug; 32(11):1747-1762
• Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People: An Open-Label Trial.
  Berger M, Li E, Rice S, Davey CG, Ratheesh A, Adams S, Jackson H, Hetrick S, Parker A, Spelman T, Kevin R, McGregor IS, McGorry P, Amminger GP
  J Clin Psychiatry. 2022 Aug; 83(5):21m14130
• UHC-The critical platform towards a healthier and safer future in 2030 and beyond.
  Biscoe G, David AM, Effler P, Hong YC, Morgan C, Raviglione MCB, Whittaker MA, Kasai T
  Lancet Reg Health West Pac. 2022 Aug; 25:100529
• Care Navigation Increases Initiation of Hepatitis C Treatment After Release From Prison in a Prospective Randomized Controlled Trial: The C-LINK Study.
  Papaluca T, Craigie A, McDonald L, Edwards A, Winter R, Hoang A, Pappas A, Waldron A, McCoy K, Stoové M, Doyle J, Hellard M, Holmes J, MacIsaac M, Desmond P, Iser D, Thompson AJ
  Open Forum Infect Dis. 2022 Aug; 9(8):ofac350
• Why risk matters for STI control: who are those at greatest risk and how are they identified?
  Traeger M, Stoové M
  Sex Health. 2022 Aug; 19(4):265-277
• "How PrEPared are you?": Knowledge of and attitudes toward PrEP among overseas-born and newly arrived gay, bisexual, and other men who have sex with men in Australia.
  Sudarto B, Chow EPF, Medland N, Fairley CK, Wright EJ, Armishaw J, Price B, Phillips TR, Ong JJ
  Front Public Health. 2022 Aug; 10:946771
• Adolescent girls' experiences of menstruation and schooling in monastic schools in Magway Region, Myanmar: A mixed-methods exploration.
  Swe ZY, Mon NO, Than KK, Azzopardi PS, Kennedy EC, Davis J, Burns LJ, Hennegan J
  Front Reprod Health. 2022 Aug; 4:893266
• Interventions to support parents who use methamphetamine: A narrative systematic review.
  Ward B, Moller C, Maybery D, Weimande B, Krause M, Dietze P, Harvey P, Kippen R, McCormick F, Lloyd-Jones M, Reupert A
  Child Youth Services Rev. 2022 Aug; 139:106525
• Bridging the gap to achieve viral hepatitis mortality targets.
  Flores E, Howell J
  Lancet Gastroenterol Hepatol. 2022 Aug; 7(8):691-692
• Controlled temperature chain for vaccination in low- and middle-income countries: a realist evidence synthesis.
  Seaman CP, Kahn AL, Kristensen D, Steinglass R, Spasenoska D, Scott N, Morgan C
  Bull World Health Organ. 2022 Aug; 100(8):491-502

July, 2022 (18)

• Repurposing of a human antibody-based microarray to explore conserved components of the signalome of the parasitic nematode Haemonchus contortus.
  Adderley J, Wang T, Ma G, Zheng Y, Young ND, Doerig C, Gasser RB
  Parasit Vectors. 2022 Jul; 15(1):273
• Constructing a 'target population': A critical analysis of public health discourse on substance use among gay and bisexual men, 2000-2020.
  Schroeder SE, Bourne A, Doyle JS, Hellard ME, Stoové M, Pedrana A
  Int J Drug Policy. 2022 Jul; 108:103808
• Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.
  Wines BD, Kurtovic L, Trist HM, Esparon S, Lopez E, Chappin K, Chan LJ, Mordant FL, Lee WS, Gherardin NA, Patel SK, Hartley GE, Pymm P, Cooney JP, Beeson JG, Godfrey DI, Burrell LM, van Zelm MC, Wheatley AK, Chung AW, Tham WH, Subbarao K, Kent SJ, Hogarth PM
  Front Immunol. 2022 Jul; 13:889372
• Potential Determinants of Cardio-Metabolic Risk among Aboriginal and Torres Strait Islander Children and Adolescents: A Systematic Review.
  McKay CD, O'Bryan E, Gubhaju L, McNamara B, Gibberd AJ, Azzopardi P, Eades S
  Int J Environ Res Public Health. 2022 Jul; 19(15)
• Expanding community engagement and advocacy in chronic viral hepatitis.
  Kpokiri EE, Elasi D, Zhang TP, Amon CL, Hicks J, Wallace J, Easterbrook P, Walsh N, El-Sayed MH, Matthews PC, Wang SH, Tucker JD, Wu D
  Lancet Gastroenterol Hepatol. 2022 Jul; 7(10):902-904
• Intact HIV proviruses persist in the brain despite viral suppression with ART.
  Cochrane CR, Angelovich TA, Byrnes SJ, Waring E, Guanizo AC, Trollope GS, Zhou J, Vue J, Senior L, Wanicek E, Jamal Eddine J, Gartner MJ, Jenkins TA, Gorry PR, Brew BJ, Lewin SR, Estes JD, Roche M, Churchill MJ
  Ann Neurol. 2022 Jul; 92(4):532-544
• Lessons for improved COVID-19 surveillance from the scale-up of malaria testing strategies.
  Kerr G, Robinson LJ, Russell TL, Macdonald J
  Malar J. 2022 Jul; 21(1):223
• Nuclear Transport of Respiratory Syncytial Virus Matrix Protein Is Regulated by Dual Phosphorylation Sites.
  Ghildyal R, Teng MN, Tran KC, Mills J, Casarotto MG, Bardin PG, Jans DA
  Int J Mol Sci. 2022 Jul; 23(14)
• Antibody dynamics in children with first or repeat Plasmodium falciparum infections.
  Rogier E, Nace D, Dimbu PR, Wakeman B, Beeson JG, Drakeley C, Tetteh K, Plucinski M
  Front Med (Lausanne). 2022 Jul; 9:869028
• Age-dependent changes in circulating Tfh cells influence development of functional malaria antibodies in children.
  Chan JA, Loughland JR, de la Parte L, Okano S, Ssewanyana I, Nalubega M, Nankya F, Musinguzi K, Rek J, Arinaitwe E, Tipping P, Bourke P, Andrew D, Dooley N, SheelaNair A, Wines BD, Hogarth PM, Beeson JG, Greenhouse B, Dorsey G, Kamya M, Hartel G, Minigo G, Feeney M, Jagannathan P, Boyle MJ
  Nat Commun. 2022 Jul; 13(1):4159
• The Global Epidemiological Transition in Cardiovascular Diseases: Unrecognised Impact of Endemic Infections on Peripheral Artery Disease.
  Agius PA, Cutts JC, Song P, Rudan I, Rudan D, Aboyans V, McDermott MM, Criqui MH, Fowkes FGR, Fowkes FJI
  J Epidemiol Glob Health. 2022 Jul; 12(3):219-223
• Level and correlates of social support in a community-based sample of Australians who primarily smoke methamphetamine.
  Leach MJ, Ward B, Kippen R, Quinn B, Agius PA, Sutton K, Peterson J, Dietze PM.
  Health Soc Care Community. 2022 Jul; 30(6):e4950-e4960
• The acceptability and usability of two HIV self-test kits among men who have sex with men: a randomised crossover trial.
  Lee DY, Ong JJ, Smith K, Jamil MS, McIver R, Wigan R, Maddaford K, McNulty A, Kaldor JM, Fairley CK, Bavinton B, Chen M, Chow EP, Grulich AE, Holt M, Conway DP, Stoové M, Wand H, Guy RJ
  Med J Aust. 2022 Jul; 217(3):149-154
• Surgical resection of chest wall sarcomas: an analysis of survival and predictors of outcome at an Australian multidisciplinary sarcoma service.
  Thakur S, Choong E, Balasooriya A, Spelman T, Wright G, Choong P
  ANZ J Surg. 2022 Jul; 92(10):2613-2619
• Piperaquine Pharmacokinetic and Pharmacodynamic Profiles in Healthy Volunteers of Papua New Guinea after Administration of Three-Monthly Doses of Dihydroartemisinin-Piperaquine.
  Millat-Martínez P, Salman S, Moore BR, Baro B, Page-Sharp M, Batty KT, Robinson LJ, Pomat W, Karunajeewa H, Laman M, Manning L, Mitjà O, Bassat Q
  Antimicrob Agents Chemother. 2022 Jul; 66(8):e0018522
• Genomic Sequencing of Dengue Virus Strains Associated with Papua New Guinean Outbreaks in 2016 Reveals Endemic Circulation of DENV-1 and DENV-2.
  Jonduo M, Neave MJ, Javati S, Abala D, Bilo E, Kini A, Kumbu J, Laman M, Robinson LJ, Makita L, Susapu M, Pomat W, Abdad MY, Williams DT, Horwood PF
  Am J Trop Med Hyg. 2022 Jul; 107(6):1234-1238
• Point-of-Care Diagnostics for Diagnosis of Active Syphilis Infection: Needs, Challenges and the Way Forward.
  Pham MD, Ong JJ, Anderson DA, Drummer HE, Stoové M
  Int J Environ Res Public Health. 2022 Jul; 19(13):8172
• Cost-effectiveness of antenatal corticosteroids and tocolytic agents in the management of preterm birth: A systematic review.
  Sebastian E, Bykersma C, Eggleston A, Eddy KE, Chim ST, Zahroh RI, Scott N, Chou D, Oladapo OT, Vogel JP
  EClinicalMedicine. 2022 Jul; 49:101496

June, 2022 (19)

• Comparison of strategies for daily surveillance of international travellers quarantined in Vanuatu, October-December 2020.
  van Gemert C, Williams W, Mariasua J, Fred D, Cornish M, Tarivonda L, Tapo PS, Atua V, Manwo O, Guyant P, Iavro L, Clark G
  Western Pac Surveill Response J. 2022 Jun; 13(2):7
• Contrasting Epidemiology and Population Genetics of COVID-19 Infections Defined by Multilocus Genotypes in SARS-CoV-2 Genomes Sampled Globally.
  Chan FHM, Ataide R, Richards JS, Narh CA
  Viruses. 2022 Jun; 14(7)
• 18F-FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial.
  Douglas A, Thursky K, Spelman T, Szer J, Bajel A, Harrison S, Tio SY, Bupha-Intr O, Tew M, Worth L, Teh B, Chee L, Ng A, Carney D, Khot A, Haeusler G, Yong M, Trubiano J, Chen S, Hicks R, Ritchie D, Slavin M
  Lancet Haematol. 2022 Jun; 9(8):e573-e584
• Review of management priorities for invasive infections in people who inject drugs: highlighting the need for patient-centred multidisciplinary care.
  Attwood LO, McKechnie M, Vujovic O, Higgs P, Lloyd-Jones M, Doyle JS, Stewardson AJ
  Med J Aust. 2022 Jun; 217(2):107-109
• The impact of COVID-19 on public health systems in the Pacific Island Countries and Territories.
  Bell L, van Gemert C, Merilles OE Jr, Cash HL, Stoové M, Hellard M
  Lancet Reg Health West Paci. 2022 Jun; 25(100498)
• The Impact of Over-The-Counter Lactic Acid Containing Vaginal Gels on the Integrity and Inflammatory State of the Vaginal Epithelium in vitro.
  Tyssen D, Hearps AC, Guntur K, Masson L, Cook S, Moulton SE, Ravel J, Bradshaw CS, Ayehunie S, Tachedjian G
  Front Reprod Health. 2022 Jun; 4:915948
• Elevated CD4+ T cell glucose metabolism in HIV+ women with diabetes mellitus.
  Butterfield TR, Hanna DB, Kaplan RC, Xue X, Kizer JR, Durkin HG, Kassaye SG, Nowicki M, Tien PC, Golub ET, Floris-Moore MA, Titanji K, Fischl MA, Heath S, Palmer CS, Landay AL, Anzinger JJ
  AIDS. 2022 Jun; 36(10):1327-1336
• Evaluating the impact of Xpert((R)) MTB/RIF on mortality from TB: are we asking the right questions?
  Chani K, Sekadde MP, Dlodlo RA, Graham SM
  Public Health Action. 2022 Jun; 12(2):53-54
• Impact of COVID-19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs.
  Traeger MW, van Santen DK, Sacks-Davis R, Asselin J, Carter A, Doyle JS, Pedrana A, Wilkinson AL, Howell J, Thatcher R, Didlick J, Donovan B, Guy R, Hellard ME, Stoové MA; Australia Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood Borne Viruses (ACCESS).
  J Viral Hepat. 2022 Jun; 29(10):908-918
• Mortality in the SuperMIX cohort of people who inject drugs in Melbourne, Australia: A prospective observational study.
  Hill PL, Stoové M, Agius PA, Maher L, Hickman M, Crawford S, Dietze P.
  Addiction. 2022 Jun; 117(12):3091-3098
• Viral load monitoring for people living with HIV in the era of test and treat: progress made and challenges ahead - a systematic review.
  Pham MD, Nguyen HV, Anderson D, Crowe S, Luchters S
  BMC Public Health. 2022 Jun; 22(1):1203
• Comparison of antibody responses and parasite clearance in artemisinin therapeutic efficacy studies in Democratic Republic of Congo and Asia.
  Cutts JC, O'Flaherty K, Zaloumis SG, Ashley EA, Chan JA, Onyamboko MA, Fanello C, Dondorp AM, Day NP, Phyo AP, Dhorda M, Imwong M, Fairhurst RM, Lim P, Amaratunga C, Pukrittayakamee S, Hien TT, Htut Y, Mayxay M, Abdul Faiz M, Takashima E, Tsuboi T, Beeson JG, Nosten F, Simpson JA, White NJ, Fowkes FJI
  J Infect Dis. 2022 Jun; 226(2):324-331
• TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis.
  Berry C, du Cros P, Fielding K, Gajewski S, Kazounis E, McHugh TD, Merle C, Motta I, Moore DAJ, Nyang'wa BT
  Trials. 2022 Jun; 23(1):484
• Prevalence, socio-demographics and service use determinants associated with disclosure of HIV/AIDS status to infected children: a systematic review and meta-analysis by 1985-2021.
  Armoon B, Fleury MJ, Higgs P, Bayat AH, Bayani A, Mohammadi R, Ahounbar E.
  Arch Public Health. 2022 Jun; 80(1):154
• High rates of resumption of injecting drug use following release from prison among men who injected drugs before imprisonment.
  Curtis M, Winter RJ, Dietze P, Wilkinson AL, Cossar RD, Stewart AC, Agius PA, Butler T, Aitken C, Kirwan A, Walker S, Stoové M
  Addiction. 2022 Jun; 117(11):2887-2898
• The impact of three progressively introduced interventions on second wave daily COVID-19 case numbers in Melbourne, Australia.
  Saul A, Scott N, Spelman T, Crabb BS, Hellard M
  BMC Infect Dis. 2022 Jun; 22(1):514
• A survey of knowledge, attitudes, barriers and support needs in providing hepatitis B care among GPs practising in Australia.
  Xiao Y, van Gemert C, Howell J, Wallace J, Richmond J, Adamson E, Thompson A, Hellard M
  BMC Prim Care. 2022 Jun; 23(1):137
• Quality newborn care in East New Britain, Papua New Guinea: measuring early newborn care practices and identifying opportunities for improvement.
  Wilson AN, Melepia P, Suruka R, Hezeri P, Kabiu D, Babona D, Wapi P, Spotswood N, Bohren MA, Vogel JP, Kelly-Hanku A, Morgan A, Beeson JG, Morgan C, Vallely LM, Waramin EJ, Scoullar MJL, Homer CSE
  BMC Pregnancy Childbirth. 2022 Jun; 22(1):462
• Latent Class Analysis of Sexual Behaviours and Attitudes to Sexually Transmitted Infections Among Gay and Bisexual Men Using PrEP.
  Traeger MW, Murphy D, Ryan KE, Asselin J, Cornelisse VJ, Wilkinson AL, Hellard ME, Wright EJ, Stoové MA
  AIDS Behav. 2022 Jun; 26(6):1808-1820

May, 2022 (31)

• The unvirtuous cycle of discrimination affecting people with hepatitis B: a multi-country qualitative assessment of key-informant perspectives.
  Freeland C, Mendola L, Cheng V, Cohen C, Wallace J
  Int J Equity Health. 2022 May; 21(1):77
• Two-Dimensional and Three-Dimensional Time-of-Flight Secondary Ion Mass Spectrometry Image Feature Extraction Using a Spatially Aware Convolutional Autoencoder.
  Gardner W, Winkler DA, Cutts SM, Torney SA, Pietersz GA, Muir BW, Pigram PJ
  Anal Chem. 2022 May; 94(22):1804-1813
• Cost-effectiveness and impact of pre-exposure prophylaxis to prevent HIV among men who have sex with men in Asia: A modelling study.
  Ten Brink DC, Martin-Hughes R, Minnery ME, Osborne AJ, Schmidt HA, Dalal S, Green KE, Ramaurtarsing R, Wilson DP, Kelly SL
  PLoS One. 2022 May; 17(5):e0268240
• Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data.
  Traeger MW, Guy R, Asselin J, Patel P, Carter A, Wright EJ, Grulich A, McManus H, Fairley CK, Chow EPF, McNulty A, Finlayson R, Bell C, Owen L, Marshall L, Russell D, O'Donnell D, Donovan B, Hellard ME, Stoové MA; Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood Borne Viruses (ACCESS) Study Group.
  Lancet Infect Dis. 2022 May; 22(8):1231-1241
• Trends in methamphetamine use, markets and harms in Australia, 2003-2019.
  Man N, Sisson SA, McKetin R, Chrzanowska A, Bruno R, Dietze PM, Price O, Degenhardt L, Gibbs D, Salom C, Peacock A
  Drug Alcohol Rev. 2022 May; 41(5):1041-1052
• Evaluating the potential cost-effectiveness of microarray patches to expand access to hepatitis B birth dose vaccination in low-and middle-income countries: A modelling study.
  Seaman CP, Mvundura M, Frivold C, Morgan C, Jarrahian C, Howell J, Hellard M, Scott N
  PLoS Glob Pub Health. 2022 May; 2(5):e0000394
• Engaging women and men in the gender-synchronised, community-based Mbereko+Men intervention to improve maternal mental health and perinatal care-seeking in Manicaland, Zimbabwe: A cluster-randomised controlled pragmatic trial.
  Comrie-Thomson L, Webb K, Patel D, Wata P, Kapamurandu Z, Mushavi A, Nicholas MA, Agius PA, Davis J, Luchters S
  J Glob Health. 2022 May; 12:04042
• Advances in Plasmodium research, an update: highlights from the Malaria in Melbourne 2021 conference.
  Adderley J, Boulet C, McCann K, McHugh E, Ioannidis LJ, Yeoh LM
  Mol Biochem Parasitol. 2022 May; 250:111487
• A log-odds system for waning and boosting of COVID-19 vaccine effectiveness.
  Szanyi J, Wilson T, Scott N, Blakely T
  Vaccine. 2022 May; 40(28):3821-3824
• Editorial: Advances on the Gametocyte Biology, Host Immunity and Vector Stages to Interrupt the Transmission of Malaria.
  Chan JA, Ngotho P, Amoah LE, Sollelis L, Reiling L
  Front Cell Infect Microbiol. 2022 May; 12:918489
• Role of COVID-19 vaccine education in discharge planning to increase community vaccination coverage.
  Tse WC, Fahey J, Doyle J, Hellard M, Howell J
  Intern Med J. 2022 May; 52(7):1284-1285
• Effect of COVID-19 restrictions and border closures on vaccine preventable diseases in Victoria, Australia, 2020-2021.
  Bhatt P, Strachan J, Easton M, Franklin L, Drewett G
  Commun Dis Intell (2018). 2022 May; 46:1-7
• Retreatment for hepatitis C virus direct acting antiviral therapy virological failure in primary and tertiary settings: the REACH-C cohort.
  Carson JM, Hajarizadeh B, Hanson J, O'Beirne J, Iser D, Read P, Balcomb A, Davies J, Doyle JS, Yee J, Martinello M, Marks P, Matthews GV, Dore GJ; REACH-C Study Group
  J Viral Hepat. 2022 May; 29(8):661-676
• The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma.
  Flores JE, Thompson AJ, Ryan M, Howell J
  Vaccines (Basel). 2022 May; 10(5):793
• Trace Residue Identification, Characterization and Longitudinal Monitoring of the Novel Synthetic Opioid beta-U10, from Discarded Drug Paraphernalia.
  West H, Fitzgerald JL, Hopkins KL, Leeming MG, DiRago M, Gerostamoulos D, Clark N, Dietze P, White JM, Ziogas J, Reid GE
  Drug Test Anal. 2022 May; 14(9):1576-1586
• HIV pre-exposure prophylaxis uptake and continuation among key populations in Cameroon: Lessons learned from the CHAMP program.
  Ndenkeh JN, Bowring AL, Njindam IM, Folem RD, Hendji Fako GC, Ngueguim FG, Gayou OL, Lepawa K, Minka CM, Batoum CM, Georges S, Temgoua E, Nzima V, Kob DA, Akiy ZZ, Philbrick W, Levitt D, Curry D, Baral S
  J Acquir Immune Defic Syndr. 2022 May; 91(1):39-46
• Social Media and Online Digital Technology Use Among Muslim Young People and Parents: Qualitative Focus Group Study.
  Douglass CH, Borthwick A, Lim MSC, Erbas B, Eren S, Higgs P
  JMIR Pediatr Parent. 2022 May; 5(2):e36858
• Reaching people receiving opioid agonist therapy at community pharmacies with hepatitis C virus: An international randomised controlled trial.
  Byrne CJ, Radley A, Inglis SK, Beer L, Palmer N, Duc Pham M, Allardice K, Wang H, Robinson E, Hermansson M, Semizarov D, Healy B, Doyle JS, Dillon JF
  Aliment Pharmacol Ther. 2022 May; 55(12):1512-1523
• Evolution and spread of a highly drug resistant strain of Mycobacterium tuberculosis in Papua New Guinea.
  Bainomugisa A, Lavu E, Pandey S, Majumdar S, Banamu J, Coulter C, Marais B, Coin L, Graham SM, du Cros P
  BMC Infect Dis. 2022 May; 22(1):437
• Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial.
  Laman M, Tavul L, Karl S, Kotty B, Kerry Z, Kumai S, Samuel A, Lorry L, Timinao L, Howard SC, Makita L, John L, Bieb S, Wangi J, Albert JM, Payne M, Weil GJ, Tisch DJ, Bjerum CM, Robinson LJ, King CL
  Lancet Infect Dis. 2022 May; 22(8):1200-1209
• "I Don't Really Know What Diabetes Is": A Qualitative Study Exploring the Experiences of Aboriginal and Torres Strait Islander Young People Aged 10 to 25 Years Living With Type 2 Diabetes in Northern and Central Australia.
  Weaver E, Freeman N, Mack S, Titmuss A, Dowler J, Corpus S, Hyatt T, Ellis E, Sanderson C, Connors C, Moore E, Silver B, Azzopardi P, Maple-Brown L, Kirkham R; Diabetes Across the Lifecourse: Northern Australia Partnership.
  Can J Diabetes. 2022 May; 46(7):722-729
• Prevalence of alcohol and other drug use in patients presenting to hospital for fall-related injuries: a systematic review.
  Lau G, Ang JY, Kim N, Gabbe BJ, Mitra B, Dietze PM, Reeder S, Beck B
  Inj Prev. 2022 May; 28(4):381-393
• Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up.
  Draper BL, Yee WL, Shilton S, Bowring A, Htay H, Nwe N, Markby J, Kyi KP, Easterbrook P, Naing W, Win TM, Aung KS, Howell J, Pedrana A, Hellard M
  BMJ Open. 2022 May; 12(5):e059639
• Criminal Justice Involvement after Release from Prison following Exposure to Community Mental Health Services among People Who Use Illicit Drugs and Have Mental Illness: a Systematic Review.
  Stewart AC, Cossar RD, Quinn B, Dietze P, Romero L, Wilkinson AL, Stoové M
  J Urban Health. 2022 May; 99:635-654
• The role of naturally acquired antimalarial antibodies in subclinical Plasmodium spp. infection.
  O'Flaherty K, Roe M, Fowkes FJI
  J Leukoc Biol. 2022 May; 111(5):1097-1105
• The impact of point-of-care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An Australian pilot study.
  Howell J, Traeger MW, Williams B, Layton C, Doyle JS, Latham N, Draper B, Bramwell F, Membrey D, McPherson M, Roney J, Stoové M, Thompson AJ, Hellard ME, Pedrana A
  J Viral Hepat. 2022 May; 29(5):375-384
• Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study.
  Phillips AN, Bershteyn A, Revill P, Bansi-Matharu L, Kripke K, Boily MC, Martin-Hughes R, Johnson LF, Mukandavire Z, Jamieson L, Meyer-Rath G, Hallett TB, Ten Brink D, Kelly SL, Nichols BE, Bendavid E, Mudimu E, Taramusi I, Smith J, Dalal S, Baggaley R, Crowley S, Terris-Prestholt F, Godfrey-Faussett P, Mukui I, Jahn A, Case KK, Havlir D, Petersen M, Kamya M, Koss CA, Balzer LB, Apollo T, Chidarikire T, Mellors JW, Parikh UM, Godfrey C, Cambiano V; HIV Modelling Consortium.
  Lancet HIV. 2022 May; 9(5):e353-e362
• Tracking the decline in Australian adolescent drinking into adulthood.
  Livingston M, Callinan S, Vashishtha R, Yuen WS, Dietze P
  Addiction. 2022 May; 117(5):1273-1281
• Mathematical Modeling for Removing Border Entry and Quarantine Requirements for COVID-19, Vanuatu.
  van Gemert C, Tarivonda L, Tapo PS, Natuman S, Clark G, Mariasua J, Scott N, Craig A, Abel M, Cornish MJ, Hellard M, Sacks-Davis R
  Emerg Infect Dis. 2022 May; 28(5):1053-1055
• HIV prevention in a time of COVID-19: A report from the HIVR4P // Virtual conference 2021.
  Laher F, Richardson SI, Smith P, Sullivan P, Abrahams AG, Asowata OE, Bitangumutwenzi P, Dabee S, Dollah A, Fernandez N, Langat RK, Bose DL, Likhitwonnawut U, Mullick R, Resop RS, Sutar J, Thompson-Hall AN, Traeger MW, Tuyishime M, Wambui J, Bekker LG, Kaleebu P, McCormack S, O'Connor DH, Warren M, Torri T, Thyagarajan B
  AIDS Res Hum Retroviruses. 2022 May; 38(5):350-358
• Declining drinking among adolescents: Are we seeing a denormalisation of drinking and a normalisation of non-drinking?
  Caluzzi G, Livingston M, Holmes J, MacLean S, Lubman D, Dietze P, Vashishtha R, Herring R, Pennay A
  Addiction. 2022 May; 117(5):1204-1212

April, 2022 (19)

• Hepatitis C antibody testing among opioid agonist therapy recipients, Victoria, Australia, 2012 to 2020.
  Dawe J, Wilkinson AL, Asselin J, Carter A, Pedrana A, Traeger MW, Thomas AJ, Curtis M, Cooper M, Howell J, Doyle JS, Hellard ME, Stoové M; EC Victoria Partnership and the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of blood borne viruses and sexually transmissible infections (ACCESS).
  Int J Drug Policy. 2022 Apr; 104:103696
• The relationship between team dynamics with healthcare coordination and clinical work satisfaction among Commune Health Workers: A Bayesian model averaging study.
  Ngo TT, Van Nguyen H, Pham TH, Van Nguyen T, Vu KD, Pham MD, Phung D, Thi Tran AN, Nguyen PT, Le PM, Thi Dao AM, Ngo HT, Van Hoang M.
  Int J Health Plann Manage. 2022 Apr; 37(5):2684-2696
• Age-based differences in quantity and frequency of consumption when screening for harmful alcohol use.
  Callinan S, Livingston M, Dietze P, Gmel G, Room R
  Addiction. 2022 Apr; 117(9):2431-2437
• Factors associated with perceived decline in the quality of drugs during the COVID-19 pandemic: Evidence from community-recruited cohorts of people who use drugs in Vancouver, Canada.
  Erica McAdam, Kanna Hayashi, Huiru Dong, Zishan Cui, Kali-Olt Sedgemore, Paul Dietze, Paige Phillips, Dean Wilson, M-J Milloy, Kora DeBeck
  Drug Alcohol Depend. 2022 Apr; 236:109471
• Hepatitis B and pregnancy: understanding the experiences of care among pregnant women and recent mothers in metropolitan Melbourne.
  Ahad M, Wallace J, Xiao Y, van Gemert C, Bennett G, Darby J, Desmond P, Hall S, Holmes J, Papaluca T, Glasgow S, Thompson A, Hellard M, Doyle J, Howell J
  BMC Public Health. 2022 Apr; 22(1):817
• The Overdose Response with Take Home Naloxone (ORTHN) project: Evaluation of health worker training, attitudes and perceptions.
  Monds LA, Bravo M, Mills L, Malcolm A, Gilliver R, Wood W, Harrod ME, Read P, Nielsen S, Dietze PM, Lenton S, Bleeker AM, Lintzeris N
  Drug Alcohol Rev. 2022 Apr; 41(5):1085-94
• Preferences for HIV Testing Services and HIV Self-Testing Distribution Among Migrant Gay, Bisexual, and Other Men Who Have Sex With Men in Australia.
  Zhang Y, Wiseman V, Applegate TL, Lourenco RA, Street DJ, Smith K, Jamil MS, Terris-Prestholt F, Fairley CK, McNulty A, Hynes A, Johnson K, Chow EPF, Bavinton BR, Grulich A, Stoové M, Holt M, Kaldor J, Guy R, Ong JJ
  Front Med (Lausanne). 2022 Apr; 9:839479
• Risk of sustained SARS-CoV-2 transmission in Queensland, Australia.
  Sanz-Leon P, Stevenson NJ, Stuart RM, Abeysuriya RG, Pang JC, Lambert SB, Kerr CC, Roberts JA
  Sci Rep. 2022 Apr; 12(1):6309
• An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples.
  MalariaGEN, Adam I, Alam MS, Alemu S, Amaratunga C, Amato R, Andrianaranjaka V, Anstey NM, Aseffa A, Ashley E, Assefa A, Auburn S, Barber BE, Barry A, Batista Pereira D, Cao J, Chau NH, Chotivanich K, Chu C, Dondorp AM, Drury E, Echeverry DF, Erko B, Espino F, Fairhurst R, Faiz A, Fernanda Villegas M, Gao Q, Golassa L, Goncalves S, Grigg MJ, Hamedi Y, Hien TT, Htut Y, Johnson KJ, Karunaweera N, Khan W, Krudsood S, Kwiatkowski DP, Lacerda M, Ley B, Lim P, Liu Y, Llanos-Cuentas A, Lon C, Lopera-Mesa T, Marfurt J, Michon P, Miotto O, Mohammed R, Mueller I, Namaik-Larp C, Newton PN, Nguyen TN, Nosten F, Noviyanti R, Pava Z, Pearson RD, Petros B, Phyo AP, Price RN, Pukrittayakamee S, Rahim AG, Randrianarivelojosia M, Rayner JC, Rumaseb A, Siegel SV, Simpson VJ, Thriemer K, Tobon-Castano A, Trimarsanto H, Urbano Ferreira M, Vélez ID, Wangchuk S, Wellems TE, White NJ, William T, Yasnot MF, Yilma D
  Wellcome Open Res. 2022 Apr; 7:136
• Editorial: Cellular and Molecular Basis in Parasitic Diseases Control: Research Trends.
  Mu J, Cao J, Feng G, Zhang Q
  Front Cell Dev Biol. 2022 Apr; 10:897858
• The Plasmodium falciparum parasitophorous vacuole protein P113 interacts with the parasite protein export machinery and maintains normal vacuole architecture.
  Bullen HE, Sanders PR, Dans MG, Jonsdottir TK, Riglar DT, Looker O, Palmer CS, Kouskousis B, Charnaud SC, Triglia T, Gabriela M, Schneider MP, Chan JA, de Koning-Ward TF, Baum J, Kazura JW, Beeson JG, Cowman AF, Gilson PR, Crabb BS
  Mol Microbiol. 2022 Apr; 117(5):1245-1262
• Antiretroviral initiation at >/=800 CD4+ cells/mm3 associated with lower HIV reservoir size.
  Rasmussen TA, Ahuja SK, Kuwanda L, Vjecha MJ, Hudson F, Lal L, Rhodes A, Chang J, Palmer S, Auberson-Munderi P, Mugerwa H, Wood R, Badal-Faesen S, Pillay S, Mngqibisa R, LaRosa A, Hildago J, Petoumenos K, Chiu C, Lutaakome J, Kitonsa J, Kabaswaga E, Pala P, Ganoza C, Fisher K, Chang C, Lewin SR, Wright EJ
  Clin Infect Dis. 2022 Apr; 75(10):1781-1791
• Genital inflammatory status and the innate immune response to contraceptive initiation.
  Radzey N, Harryparsad R, Meyer B, Chen PL, Gao X, Morrison C, Taku O, Williamson AL, Mehou-Loko C, d'Hellencourt FL, Buck G, Smit J, Strauss J, Nanda K, Ahmed K, Beksinska M, Serrano M, Bailey V, Masson L, Deese J
  Am J Reprod Immunol. 2022 Apr; 88(2):e13542
• Anti-Gametocyte Antigen Humoral Immunity and Gametocytemia During Treatment of Uncomplicated Falciparum Malaria: A Multi-National Study.
  O'Flaherty K, Chan JA, Cutts JC, Zaloumis SG, Ashley EA, Phyo AP, Drew DR, Dondorp AM, Day NP, Dhorda M, Fairhurst RM, Lim P, Amaratunga C, Pukrittayakamee S, Hien TT, Htut Y, Mayxay M, Faiz MA, Mokuolu OA, Onyamboko MA, Fanello C, Takashima E, Tsuboi T, Theisen M, Nosten F, Beeson JG, Simpson JA, White NJ, Fowkes FJI.
  Front Cell Infect Microbiol. 2022 Apr; 12:804470
• STRIVE PNG: using a partnership-based approach in implementation research to strengthen surveillance and health systems in Papua New Guinea.
  Farquhar R, Dori A, MacCana S, Tefuarani N, Lavu E, Barry A, Karl S, Makita L, Robinson L, Laman M
  Health Res Policy Syst. 2022 Apr; 20(1):35
• Mathematical modelling of the mosquito Aedes polynesiensis in a heterogeneous environment.
  Heath K, Bonsall MB, Marie J, Bossin HC
  Math Biosci. 2022 Apr; 348:108811
• COVID-19 vaccine wastage in the midst of vaccine inequity: causes, types and practical steps.
  Lazarus JV, Abdool Karim SS, van Selm L, Doran J, Batista C, Ben Amor Y, Hellard M, Kim B, Kopka CJ, Yadav P
  BMJ Glob Health. 2022 Apr; 7(4)
• Perspectives on the use of modelling and economic analysis to guide HIV programmes in sub-Saharan Africa.
  Modelling to Inform HIV Programmes in sub-Saharan Africa (MIHPSA) Working Group (including Kerr CC)
  Lancet HIV. 2022 Apr; 9(7):e517-e520
• Plasmodium vivax - How hidden reservoirs hinder global malaria elimination.
  Angrisano F, Robinson LJ
  Parasitol Int. 2022 Apr; 87:102526

March, 2022 (31)

• Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review.
  Wirtz C, Mohamed Y, Engel D, Sidibe A, Holloway M, Bloem P, Kumar S, Brotherton J, Reis V, Morgan C
  Vaccine. 2022 Mar; 40(Suppl 1):A116-A123
• Quality of care for children with acute respiratory infections in health facilities: a comparative analysis of assessment tools.
  Quach A, Tosif S, Graham SM, von Mollendorf C, Mulholland K, Graham H, Duke T, Russell FM; ARI Review group
  J Glob Health. 2022 Mar; 12:10003
• Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol.
  Marukutira T, Moore KP, Hellard M, Richmond J, Turner K, Pedrana AE, Melody S, Johnston FH, Owen L, Van Den Boom W, Scott N, Thompson A, Iser D, Spelman T, Veitch M, Stoové MA, Doyle J
  BMJ Open. 2022 Mar; 12(3):e056120
• Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020.
  Wilkinson AL, van Santen DK, Traeger MW, Sacks-Davis R, Asselin J, Scott N, Harney BL, Doyle JS, El-Hayek C, Howell J, Bramwell F, McManus H, Donovan B, Stoové M, Hellard M, Pedrana A
  Int J Drug Policy. 2022 Mar; 103:103655
• Treatment of Rifampicin-Resistant Tuberculosis Disease and Infection in Children: Key Updates, Challenges and Opportunities.
  Howell P, Achar J, Huang GKL, Mariandyshev A, Schaaf HS, Garcia-Prats AJ
  Pathogens. 2022 Mar; 11(4):381
• Diagnostic Challenges in Childhood Pulmonary Tuberculosis-Optimizing the Clinical Approach.
  Gunasekera KS, Vonasek B, Oliwa J, Triasih R, Lancioni C, Graham SM, Seddon JA, Marais BJ
  Pathogens. 2022 Mar; 11(4):382
• Impacts of COVID-19-related service disruptions on TB incidence and deaths in Indonesia, Kyrgyzstan, Malawi, Mozambique, and Peru: Implications for national TB responses.
  Martin-Hughes R, Vu L, Cheikh N, Kelly SL, Fraser-Hurt N, Shubber Z, Manhic I, Mbendera K, Girma B, Pambudi I, Rıos J, Elmira A, Harimurti P, Hafez R, Nicolas Bayona Garcia J, Palmer T, Roberts A, Gorgens M, Wilson D
  PLoS Glob Pub Health. 2022 Mar; 2(3):e0000219
• A pan-genotype hepatitis C virus viral vector vaccine generates T-cells and neutralizing antibodies in mice.
  Donnison T, McGregor J, Chinnakannan S, Hutchings C, Center RJ, Poumbourios P, Klenerman P, Drummer HE, Barnes E
  Hepatology. 2022 Mar; 76(4):1190-1202
• Developing sero-diagnostic tests to facilitate Plasmodium vivax Serological Test-and-Treat approaches: modeling the balance between public health impact and overtreatment.
  Obadia T, Nekkab N, Robinson LJ, Drakeley C, Mueller I, White MT
  BMC Med. 2022 Mar; 20(1):98
• Understanding how to live with hepatitis B: a qualitative investigation of peer advice for Chinese people living with hepatitis B in Australia.
  Wallace J, Xiao Y, Howell J, Thompson A, Allard N, Adamson E, Richmond J, Hajarizadeh B, Eagle M, Doyle J, Hellard M
  BMC Public Health. 2022 Mar; 22(1):536
• Interventions to eliminate hepatitis C: which ones suit your community?
  Wade AJ, Doyle JS
  Lancet Gastroenterol Hepatol. 2022 Mar; 7(5):383-384
• Barriers to accessing HIV pre-exposure prophylaxis for Medicare-ineligible people in Melbourne, Australia: analysis of patients attending the PrEPMe Clinic.
  Cornelisse VJ, Armishaw J, Catton M, Murphy D, Wright EJ
  Med J Aust. 2022 Mar; 216(6):320-321
• Perspectives of health and community stakeholders on community-delivered models of malaria elimination in Lao People's Democratic Republic: A qualitative study.
  Oo MC, Phongluxa K, Oo WH, Kounnavong S, Xayyavong S, Louangphaxay C, Htike W, Cutts JC, Thu KM, Hkawng GN, Fowkes FJI
  PLoS One. 2022 Mar; 17(3):e0264399
• Letter to the editor RE: Lake et al., 2022 comment on Fulford et al., 2021 'A point-of-care lateral flow assay for neutralizing antibodies against SARS-CoV-2'.
  Anderson DA, Godfrey DI
  EBioMedicine. 2022 Mar; 77:103899
• Health service utilisation and access for people who inject drugs during COVID-19.
  Efunnuga H, Higgs P, Walker S, O'Keefe D
  Drug Alcohol Rev. 2022 Mar; 41(6):1304-1310
• Making child's play of tolerance: Defining the immune-viral interplay during combination entecavir and pegylated interferon therapy for immune tolerant hepatitis B infection.
  Howell J, Hellard M
  Hepatology. 2022 Mar; 76(3):554-557
• Preventing a cluster from becoming a new wave in settings with zero community COVID-19 cases.
  Abeysuriya RG, Delport D, Stuart RM, Sacks-Davis R, Kerr CC, Mistry D, Klein DJ, Hellard M, Scott N
  BMC Infect Dis. 2022 Mar; 22(1):232
• Australian consensus recommendations for the management of hepatitis B.
  Lubel JS, Strasser SI, Thompson AJ, Cowie BC, MacLachlan J, Allard NL, Holmes J, Kemp WW, Majumdar A, Iser D, Howell J, Matthews GV
  Med J Aust. 2022 Mar; 216(9): 478-486
• Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs.
  McGregor J, Hardy JM, Lay CS, Boo I, Piontek M, Suckow M, Coulibaly F, Poumbourios P, Center RJ, Drummer HE
  J Virol. 2022 Mar; 96(5): e01675-21
• Quantification of the dynamics of antibody response to malaria to inform sero-surveillance in pregnant women.
  Dharmaratne ADVTT, Dini S, O'Flaherty K, Price DJ, Beeson J, McGready R, Nosten F, Fowkes FJI, Simpson JA, Zaloumis SG
  Malar J. 2022 Mar; 21(1):75
• HIV related stigma associated with social support, alcohol use disorders, depression, anxiety, and suicidal ideation among people living with HIV: a systematic review and meta-analysis.
  Armoon B, Fleury MJ, Bayat AH, Fakhri Y, Higgs P, Moghaddam LF, Gonabadi-Nezhad L
  Int J Ment Health Syst. 2022 Mar; 16(1):17
• Can malaria parasites be spontaneously cleared?
  Roe MS, O'Flaherty K, Fowkes FJI
  Trends Parasitol. 2022 Mar; 38(5):356-364
• "It's not just the hit itself": the social practice of injecting drug use among gay and bisexual men in Australia.
  Schroeder SE, Bourne A, Doyle J, Stoove M, Hellard M, Pedrana A
  Int J Drug Policy. 2022 Mar; 103:103642
• Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patients.
  Draper B, Yee WL, Pedrana A, Kyi KP, Qureshi H, Htay H, Naing W, Thompson AJ, Hellard M, Howell J
  Lancet Reg Health West Pac. 2022 Mar; 20:100359
• Reconceptualizing bacterial vaginosis treatment.
  Masson L, Abrahams AG, Manhanzva MT
  Nat Microbiol. 2022 Mar; 7(3):365-366
• Community perceptions and acceptability of mass drug administration for the control of neglected tropical diseases in Asia-Pacific countries: A systematic scoping review of qualitative research.
  Mitchell E, Kelly-Hanku A, Krentel A, Romani L, Robinson LJ, Vaz Nery S, Kaldor J, Steer AC, Bell S
  PLoS Negl Trop Dis. 2022 Mar; 16(3):e0010215
• WHO method for estimating congenital syphilis to inform surveillance and service provision, Paraguay.
  Heath K, Alonso M, Aguilar G, Samudio T, Korenromp E, Rowley J, Suleiman A, Shwe YY, Htin KCW, Ishikawa N, Owiredu MN, Taylor M
  Bull World Health Organ. 2022 Mar; 100(3):231-236
• An observational prospective cohort study of naloxone use at witnessed overdoses, Kazakhstan, Kyrgyzstan, Tajikistan, Ukraine.
  Dietze P, Gerra G, Poznyak V, Campello G, Kashino W, Dzhonbekov D, Kiriazova T, Nikitin D, Terlikbayeva A, Krupchanka D, Busse A
  Bull World Health Organ. 2022 Mar; 100(3):187-195
• A profile of the Visitect(R) CD4 and Visitect(R) CD4 advanced disease for management of people living with HIV.
  Pham MD, Stoove M, Crowe S, Luchters S, Anderson D`
  Expert Rev Mol Diagn. 2022 Mar; 22(3):247-252
• A multi-site, nurse-coordinated hepatitis C model of care in primary care and community services in Melbourne, Australia.
  Harney BL, Whitton B, Paige E, Brereton R, Weiss R, Membrey D, Wade AJ, Iser D, Kemp W, Roberts SK, Spelman T, Sacks-Davis R, Hellard ME, Doyle JS
  Liver Int. 2022 Mar; 42(3):522-531
• Emergency department presentations in the first weeks following release from prison among men with a history of injecting drug use in Victoria, Australia: A prospective cohort study.
  Cossar RD, Stewart AC, Wilkinson AL, Dietze P, Ogloff JRP, Aitken C, Butler T, Kinner SA, Curtis M, Walker S, Kirwan A, Stoové M
  Int J Drug Policy. 2022 Mar; 101:103532

February, 2022 (23)

• Area-level social and economic factors and the local incidence of SARS-CoV-2 infections in Victoria during 2020.
  Roder C, Maggs C, McNamara BJ, O'Brien D, Wade AJ, Bennett C, Pasco JA, Athan E
  Med J Austr. 2022 Feb; 216(7):349-356
• Response to commentaries: (De)normalization of drinking and its implications for young people, sociality, culture and epidemiology.
  Caluzzi G, Livingston M, Holmes J, MacLean S, Lubman DI, Dietze P, Vashishtha R, Herring R, Pennay A
  Addiction. 2022 Feb; 117(5):1217-1219
• The Importance of Prisons in Achieving Hepatitis C Elimination: Insights from the Australian Experience.
  Winter RJ, Holmes JA, Papaluca TJ, Thompson AJ
  Viruses. 2022 Feb; 14(3):497
• PacBio long-read amplicon sequencing enables scalable high-resolution population allele typing of the complex CYP2D6 locus.
  Charnaud S, Munro JE, Semenec L, Mazhari R, Brewster J, Bourke C, Ruybal-Pesántez S, James R, Lautu-Gumal D, Karunajeewa H, Mueller I, Bahlo M
  Commun Biol. 2022 Feb; 5(1):168
• A revised mechanism for how Plasmodium falciparum recruits and exports proteins into its erythrocytic host cell.
  Gabriela M, Matthews KM, Boshoven C, Kouskousis B, Jonsdottir TK, Bullen HE, Modak J, Steer DL, Sleebs BE, Crabb BS, Koning-Ward TF, Gilson PR
  PLoS Pathog. 2022 Feb; 18(2):e1009977
• A Quantitative Approach to Unravel the Role of Host Genetics in IgG-FcgammaR Complex Formation After Vaccination.
  Lemke MM, Theisen RM, Bozich ER, McLean MR, Lee CY, Lopez E, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kratochvil S, Wines BD, Hogarth PM, Kent SJ, Chung AW, Arnold KBKelly B Arnold
  Front Immunol. 2022 Feb; 13:820148
• COVID-19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews.
  Price O, Dietze PM, Maher L, Crawford S, Peacock A
  Drug Alcohol Rev. 2022 Feb; 41(5):1025-1028
• Structure of the Pf12 and Pf41 heterodimeric complex of Plasmodium falciparum 6-cysteine proteins.
  Dietrich MH, Chan LJ, Adair A, Boulet C, O'Neill MT, Tan LL, Keremane S, Mok YF, Lo AW, Gilson P, Tham WH
  FEMS Microbes. 2022 Feb; 3: xtac005
• Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case.
  Kochhar S, Barreira D, Beattie P, Cavaleri M, Cravioto A, Frick MW, Ginsberg AM, Hudson I, Kaslow DC, Kurtz S, Lienhardt C, Madhi SA, Morgan C, Momeni Y, Patel D, Rees H, Rogalski-Salter T, Schmidt A, Semete-Makokotlela B, Voss G, White RG, Zignol M, Giersing B
  Vaccine. 2022 Feb; 40(12):1681-1690
• Effectiveness of COVID-19 Vaccines against Delta Variant (B.1.617.2): A Meta-Analysis.
  Mahumud RA, Ali MA, Kundu S, Rahman MA, Kamara JK, Renzaho AMN
  Vaccines (Basel). 2022 Feb; 10(2):277
• Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial.
  Tavul L, Laman M, Howard C, Kotty B, Samuel A, Bjerum C, O'Brian K, Kumai S, Amuga M, Lorry L, Kerry Z, Kualawi M, Karl S, Makita L, John LN, Bieb S, Wangi J, Weil GJ, Goss CW, Tisch DJ, Pomat W, King CL, Robinson LJ
  PLoS Negl Trop Dis. 2022 Feb; 16(2):e0010096
• Cell biological analysis reveals an essential role for Pfcerli2 in erythrocyte invasion by malaria parasites.
  Liffner B, Balbin JM, Shami GJ, Siddiqui G, Strauss J, Frölich S, Heinemann GK, Edwards EM, Alder A, Wichers JS, Creek DJ, Tilley L, Dixon MWA, Gilberger TW, Wilson DW
  Commun Biol. 2022 Feb; 5(1):121
• Modelling the impact of reopening schools in the UK in early 2021 in the presence of the alpha variant and with roll-out of vaccination against SARS-CoV-2.
  Panovska-Griffiths J, Stuart RM, Kerr CC, Rosenfield K, Mistry D, Waites W, Klein DJ, Bonell C, Viner RM
  J Math Anal Appl. 2022 Feb; 514(2):126050
• Global diversity and balancing selection of 23 leading Plasmodium falciparum candidate vaccine antigens.
  Naung MT, Martin E, Munro J, Mehra S, Guy AJ, Laman M, Harrison GLA, Tavul L, Hetzel M, Kwiatkowski D, Mueller I, Bahlo M, Barry AE
  PLoS Comput Biol. 2022 Feb; 18(2):e1009801
• Updated guidelines for child and adolescent TB.
  S M Graham, F Amanullah
  Int J Tuberc Lung Dis. 2022 Feb; 26(2):81-84
• Integration of other services with human papillomavirus vaccination; lessons from earlier in the life course highlight the need for new policy and implementation evidence.
  Morgan C, Giattas MR, Holroyd T, Pfitzer A, Engel D, Sidibe A, Holloway M, Bloem P, Fields R, Shimp L, Kumar S
  Vaccine. 2022 Feb; 40:A94-A99
• Understanding preferences for type of take-home naloxone device: international qualitative analysis of the views of people who use opioids.
  Neale J, Farrugia A, Campbell AN, Dietze P, Dwyer R, Fomiatti R, Jones JD, Comer SD, Fraser S, Strang J
  Drugs: Education, Prevention and Policy. 2022 Feb; 29(2):109-120
• Turning the tide on hepatitis C-related liver transplantation: the return on investment in hepatitis C treatment in Australia and New Zealand.
  Howell J, Majumdar A, Fink M, Byrne M, McCaughan G, Strasser SI, Crawford M, Hodgkinson P, Stuart KA, Tallis C, Chen J, Wigg A, Jones R, Jaques B, Jeffrey G, Adams L, Wallace MC, Munn S, Gane E, Thompson A, Gow P
  Liver Transpl. 2022 Feb; 28(2):236-246
• An antigenically diverse, representative panel of envelope glycoproteins for HCV vaccine development.
  Salas JH, Urbanowicz RA, Guest JD, Frumento N, Figueroa A, Clark KE, Keck Z, Cowton VM, Cole SJ, Patel AH, Fuerst TR, Drummer HE, Major M, Tarr AW, Ball JK, Law M, Pierce BG, Foung SKH, Bailey JR
  Gastroenterology. 2022 Feb; 162(2):562-574
• COVID-19 vaccine acceptability among people in Australia who inject drugs: Implications for vaccine rollout.
  Dietze PM, Hall C, Price O, Stewart AC, Crawford S, Peacock A, Maher L
  Drug Alcohol Rev. 2022 Feb; 41(2):484-487
• Alcohol consumption and illicit drug use among young music festival attendees in Australia
  Douglass CH, Raggatt, M, Wright CJC, Reddan H, O'Connell H, Lim MSC, Dietze PM
  Drugs - Educt Prevent Pol. 2022 Feb; 29(2):175-181
• Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a 'moral hazard' associated with naloxone supply.
  Tse WC, Djordjevic F, Borja V, Picco L, Lam T, Olsen A, Larney S, Dietze P, Nielsen S
  Int J Drug Policy. 2022 Feb; 100:103513
• Critical timing and extent of public health interventions to control outbreaks dominated by SARS-CoV-2 variants in Australia: a mathematical modelling study.
  Zou Z, Fairley CK, Shen M, Scott N, Xu X, Li Z, Li R, Zhuang G, Zhang L
  Int J Infect Dis. 2022 Feb; 115:154-165

January, 2022 (43)

• Intent to Be Vaccinated against COVID-19 in Victoria, Australia.
  Heath K, Altermatt A, Saich F, Pedrana A, Fletcher-Lartey S, Bowring AL, Stoové M, Danchin M, Kaufman J, Gibney KB, Hellard M
  Vaccines (Basel). 2022 Jan; 10(2)
• Exploring stigma associated with mental health conditions and alcohol and other drug use among people from migrant and ethnic minority backgrounds: a protocol for a systematic review of qualitative studies.
  Douglass CH, Lim MSC, Block K, Onsando G, Hellard M, Higgs P, Livingstone C, Horyniak D
  Syst Rev. 2022 Jan; 11(1):12
• The feasibility of a drug consumption room in the Australian Capital Territory.
  Kirwan A, Winter R, Gunn J, Djordjevic F, Curtis M, Gough C, Dietze PM
  Drug Alcohol Rev. 2022 Jan; 41(6):1440-1443
• More than saving lives: Qualitative findings of the UNODC/WHO Stop Overdose Safely (S-O-S) project.
  Walker S, Dietze P, Poznyak V, Campello G, Kashino W, Dzhonbekov D, Kiriazova T, Nikitin D, Terlikbayeva A, Nevendorff L, Busse A, Krupchanka D
  Int J Drug Policy. 2022 Jan; 100:103482
• Population-level genome-wide STR discovery and validation for population structure and genetic diversity assessment of Plasmodium species.
  Han J, Munro JE, Kocoski A, Barry AE, Bahlo M
  PLoS Genet. 2022 Jan; 18(1):e1009604
• [Potential challenges for large-scale uses of RTS, S/AS01 vaccine in malaria-endemic areas].
  Feng GQ
  Chin J Schistosomiasis Control. 2022 Jan; 33(6):553-554
• The Australian living guidelines for the clinical care of people with COVID-19: What worked, what didn't and why, a mixed methods process evaluation.
  Turner T, Elliott J, Tendal B, Vogel JP, Norris S, Tate R, Green S; National COVID-19 Clinical Evidence Taskforce.
  PLoS One. 2022 Jan; 17(1):e0261479
• "It's a revolving door": Ego-depletion among prisoners with injecting drug use histories as a barrier to post-release success.
  Schroeder SE, Drysdale K, Lafferty L, Baldry E, Marshall AD, Higgs P, Dietze P, Stoové M, Treloar C
  Int J Drug Policy. 2022 Jan; 101:103571
• Vector composition, abundance, biting patterns and malaria transmission intensity in Madang, Papua New Guinea: assessment after 7 years of an LLIN-based malaria control programme.
  Keven JB, Katusele M, Vinit R, Rodríguez-Rodríguez D, Hetzel MW, Robinson LJ, Laman M, Karl S, Walker ED
  Malar J. 2022 Jan; 21(1):7
• Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison.
  Curtis M, Berk J, Larney S, Rich JD, Stoové M
  Int J Drug Policy. 2022 Jan; 100:103572
• Exploring hepatitis C virus testing and treatment engagement over time in Melbourne, Australia: a study protocol for a longitudinal cohort study (EC-Experience Cohort study).
  O'Keefe D, Gunn J, Ryan K, Djordjevic F, Kerr P, Gold J, Elsum I, Layton C, Chan K, Dietze P, Higgs P, Doyle J, Stoové MA, Hellard M, Pedrana AE
  BMJ Open. 2022 Jan; 12(1):e057618
• Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland.
  Shattock AJ, Le Rutte EA, Robert P Dünner RP, Sen S, Kelly SL, Chitnis N, Penny MA
  Epidemics. 2022 Jan; 38:100535
• Pacific island nations face an urgent need for actions and future research on COVID-19.
  Gay N, van Gemert C, Merilles OE Jr, Georgel P
  Lancet Reg Health West Pac. 2022 Jan; 18:100326
• A summary of the sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment.
  Sherrill-Mix S, Yang M, Aldrovandi GM, Brenchley J, Bushman F, Collman R, Dandekar S, Klatt NR, Lagenaur LA, Landay A, Paredes R, Tachedjian G, Turpin JA, Serrano-Villar S, Lozupone C, Ghosh M
  AIDS Res Hum Retroviruses. 2022 Jan; 38(3):173-180
• Cohort Profile: The Melbourne Injecting Drug User Cohort Study (SuperMIX).
  Van Den Boom W, Quiroga MDM, O'Keefe D, Kumar D, Hill PL, Scott N, Agius PA, Higgs P, Kerr T, Maher L, Hickman M, Stoové M, Dietze P
  Int J Epidemiol. 2022 Jan; 51(3):e123-e130
• Adults with Plasmodium falciparum malaria have higher magnitude and quality of circulating T-follicular helper cells compared to children.
  Oyong DA, Loughland JR, Soon MSF, Chan JA, Andrew D, Wines BD, Hogarth PM, Olver SD, Collinge AD, Varelias A, Beeson JG, Kenangalem E, Price RN, Anstey NM, Minigo G, Boyle MJ
  EBioMedicine. 2022 Jan; 75:103784
• Screening for risky drinkers among hospitalised inpatients using the AUDIT: A feasibility, point prevalence and data linkage study.
  O'Brien H, Di Rico R, Dean E, Smoker G, Lloyd-Jones M, McKechnie M, Dietze PM, Doyle JS
  Drug Alcohol Rev. 2022 Jan; 41(1):293-302
• Brand inequity in access to COVID-19 vaccines.
  Sheel M, McEwen S, Davies SE
  Lancet Reg Health West Pac. 2022 Jan; 18:100366
• The role of parental control and support in declining adolescent drinking: A multi-level study across 30 European countries.
  Vashishtha R, Pennay A, Dietze PM, Livingston M
  Alcoho; Alcohol. 2022 Jan; 57(4):470-476
• Inter-relationships among key reproductive health indicators in sub-Saharan Africa focusing on the central role of maternal literacy.
  Woldegiorgis MA, Meyer D, Hiller JE, Mekonnen W, Bhowmik J
  Int Health. 2022 Jan; 14(4):421-433
• Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019.
  Wilkinson AL, Pedrana A, Traeger MW, Asselin J, El-Hayek C, Nguyen L, Polkinghorne V, Doyle JS, Thompson AJ, Howell J, Scott N, Dimech W, Guy R, Hellard M, Stoové M; EC Victoria Partnership and the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of blood borne viruses and sexually transmissible infections (ACCESS)
  Epidemiol Infect. 2022 Jan; 150:e7
• Drug injection in Iranian prisons: evidence from the National Rapid Assessment and Response (RAR) survey, 2017
  Karimi SE, Vameghi M, Roshanfekr P, Ahmadi S, Ali D, Higgs P
  J Subst Use. 2022 Jan; 27(3): 272-276
• Social impacts of living with chronic hepatitis B in South Sudanese community in Australia.
  Mude WW, Fisher CM, Richmond J, Gautier RL, Wallace J
  Ethn Health. 2022 Jan; 27(3):529-541
• Understanding 'risk' in families living with mixed blood-borne viral infection status: The doing and undoing of 'difference'.
  Persson A, Smith AK, Wallace J, Valentine K, Bryant J, Hamilton M, Newman CE
  Health. 2022 Jan; 26(3):284-301
• Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A.
  Xu H, Locarnini S, Wong D, Hammond R, Colledge D, Soppe S, Huynh T, Shaw T, Thompson AJ, Revill PA, Hogarth PM, Wines BD, Walsh R, Warner N
  J Hepatol. 2022 Jan; 76(1):34-45
• Examining trends in the representation of young people and alcohol in Australian newspapers over twenty years (2000-2019).
  Pennay A, Cook M, MacLean S, Lubman DI, Dietze P, Herring R, Caluzzi G, Vashishtha R, Livingston M
  Int J Drug Policy. 2022 Jan; 99:103461
• Correlates of anxiety and depression in a community cohort of people who smoke methamphetamine.
  Duncan Z, Kippen R, Sutton K, Ward B, Agius PA, Quinn B, Dietze P
  Aust N Z J Psychiatry. 2022 Jan; 56(8):964-973
• Psychiatric well-being among men leaving prison reporting a history of injecting drug use: A longitudinal analysis.
  Stewart AC, Cossar R, Wilkinson AL, Scott N, Dietze P, Quinn B, Kinner SA, Aitken C, Walker S, Curtis M, Butler T, Ogloff JRP, Stoové M
  Aust N Z J Psychiatry. 2022 Jan; 56(8):1034-1043
• It is time for us all to embrace person-centred language for people in prison and people who were formerly in prison.
  Harney BL, Korchinski M, Young P, Scow M, Jack K, Linsley P, Bodkin C, Brothers TD, Curtis M, Higgs P, Mead TS, Hart A, Kilroy D, Bonn M, Bartlett SR
  Int J Drug Policy. 2022 Jan; 99:103455
• Cost effectiveness of simplified HCV screening-and-treatment interventions for people who inject drugs in Dar-es-Salaam, Tanzania.
  Mohamed Z, Scott N, Nayagam S, Rwegasha J, Mbwambo J, Thursz MR, Brown AS, Hellard M, Lemoine M
  Int J Drug Policy. 2022 Jan; 99:103458
• The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009-2019.
  Harney BL, Sacks-Davis R, van Santen DK, Traeger M, Wilkinson AL, Asselin J, El-Hayek C, Fairley CK, Roth N, Bloch M, Matthews G, Donovan B, Guy R, Stoové M, Hellard ME, Doyle JS; Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood-borne Viruses (ACCESS).
  Clin Infect Dis. 2022 Jan; 74(10):1804-1811
• High effectiveness of broad access direct-acting antiviral therapy for hepatitis C in an Australian real-world cohort: The REACH-C Study
  Yee J, Carson JM, Hajarizadeh B, Hanson J, O'Beirne J, Iser D, Read P, Balcomb A, Doyle JS, Davies J, Martinello M, Marks P, Dore GJ, Matthews GV; REACH-C Study Group.
  Hepatol Commun. 2022 Jan; 6(3):496-512
• An examination of the role of changes in country-level leisure time internet use and computer gaming on adolescent drinking in 33 European countries.
  Vashishtha R, Holmes J, Pennay A, Dietze PM, Livingston M
  Int J Drug Policy. 2022 Jan; 100:103508
• The cost and impact of distributing naloxone to people who are prescribed opioids to prevent opioid-related deaths: findings from a modelling study.
  Nielsen S, Scott N, Tidhar T, Quiroga MDM, Lenton S, Dietze P
  Addiction. 2022 Jan; 117(4):1009-1019
• Initial Experience with the NAVIO Robotic-Assisted Total Knee Replacement-Coronal Alignment Accuracy and the Learning Curve.
  Collins K, Agius PA, Fraval A, Petterwood J
  J Knee Surg. 2022 Jan; 35(12):1295-1300
• Awareness, Value and Use of the Australian living guidelines for the clinical care of people with COVID-19: An impact evaluation.
  Millard T, Elliott JH, Green S, Tendal B, Vogel JP, Norris S, Tate R, Turner T; National COVID-19 Clinical Evidence Taskforce.
  J Clin Epidemiol. 2022 Jan; 143:11-21
• Promoting adolescent health through integrated human papillomavirus vaccination programs: The experience of Togo.
  Engel D, Afeli ADJ, Morgan C, Zeck W, Ross DA, Vyankandondera J, Bloem P, Adjeoda KR
  Vaccine. 2022 Jan; 40(Suppl 1):A100-A106
• The effectiveness of interventions on nutrition social behaviour change communication in improving child nutritional status within the first 1000 days: Evidence from a systematic review and meta-analysis.
  Mahumud RA, Uprety S, Wali N, Renzaho AMN, Chitekwe S
  Matern Child Nutr. 2022 Jan; 18(1):e13286
• The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality.
  Karlsen TH, Sheron N, Zelber-Sagi S, Carrieri P, Dusheiko G, Bugianesi E, Pryke R, Hutchinson SJ, Sangro B, Martin NK, Cecchini M, Dirac MA, Belloni A, Serra-Burriel M, Ponsioen CY, Sheena B, Lerouge A, Devaux M, Scott N, Hellard M, Verkade HJ, Sturm E, Marchesini G, Yki-Järvinen H, Byrne CD, Targher G, Tur-Sinai A, Barrett D, Ninburg M, Reic T, Taylor A, Rhodes T, Treloar C, Petersen C, Schramm C, Flisiak R, Simonova MY, Pares A, Johnson P, Cucchetti A, Graupera I, Lionis C, Pose E, Fabrellas N, Ma AT, Mendive JM, Mazzaferro V, Rutter H, Cortez-Pinto H, Kelly D, Burton R, Lazarus JV, Ginès P, Buti M, Newsome PN, Burra P, Manns MP
  Lancet. 2022 Jan; 399(10319):61-116
• Care of older people and people requiring palliative care with COVID-19: guidance from the Australian National COVID-19 Clinical Evidence Taskforce.
  Cheyne S, Lindley RI, Smallwood N, Tendal B, Chapman M, Fraile Navarro D, Good PD, Jenkin P, McDonald S, Morgan D, Murano M, Millard T, Naganathan V, Srikanth V, Tuffin P, Vogel J, White H, Chakraborty SP, Whiting E, William L, Yates PM, Callary M, Elliott J, Agar MR; National COVID-19 Clinical Evidence Taskforce.
  Med J Aust. 2022 Jan; 216(4):203-208
• Costs and impact on HIV transmission of a switch from a criminalisation to a public health approach to injecting drug use in eastern Europe and central Asia: a modelling analysis.
  Ward Z, Stone J, Bishop C, Ivakin V, Eritsyan K, Deryabina A, Low A, Cepeda J, Kelly SL, Heimer R, Cook R, Altice FL, Litz T, Terlikbayeva A, El-Bassel N, Havarkov D, Fisenka A, Boshnakova A, Klepikov A, Saliuk T, Deshko T, Vickerman P
  Lancet HIV. 2022 Jan; 9(1):e42-e53
• Changes in illicit drug use and markets with the COVID-19 pandemic and associated restrictions: Findings from the Ecstasy and Related Drugs Reporting System, 2016-2020.
  Price O, Man N, Bruno R, Dietze P, Salom C, Lenton S, Grigg J, Gibbs D, Wilson T, Degenhardt L, Chan R, Thomas N, Peacock A
  Addiction. 2022 Jan; 117(1):182-194
• Assessment of the cost-effectiveness of Australia’s risksharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study.
  Scott N, Palmer A, Tidhar T, Stoové M, Sacks-Davis R, Doyle JS, Pedrana A, Thompson AJ, Wilson DP, Hellard M
  Lancet Reg Health - West Pac. 2022 Jan; 18:100316